KR1 Plc

Post-Annual General Meeting Information • Nov 20, 2025

National Storage Mechanism | Additional information

RNS Number : 4192I

KR1 PLC

20 November 2025

Thursday, 20 November 2025

KR1 plc (the "Company")

Results of Annual and Extraordinary General Meetings

KR1 plc (KR1:AQSE), a leading digital asset company, is pleased to announce that all Resolutions were duly passed at the Annual General Meeting and the Extraordinary General Meeting of the Company held earlier today.

The votes cast at the meetings are set out in the tables below. 

Annual General Meeting

Resolution	For		Against		Total votes cast as % of Issued Share Capital	Votes Withheld
Number of Votes	% of shares voted	Number of Votes	% of shares voted
1. To receive the 2024 report & accounts.	53,598,207	99.8%	90,392	0.2%	30.2%	174,225
2. To re-appoint PKF Littlejohn LLP  as auditors.	53,577,269	98.3%	94,392	1.7%	30.7%	191,163
3. To re-elect Rhys Davies as a director.	50,817,145	94.7%	2,841,555	5.3%	30.2%	204,124
4. To re-elect Aeron Buchanan as a director.	53,466,139	99.6%	192,561	0.4%	30.2%	204,124
5. To re-elect Mona Elisa as a director.	53,165,051	99.1%	493,649	0.9%	30.2%	204,124
6. To re-elect George McDonaugh as a director.	52,081,570	97.0%	1,589,130	3.0%	30.2%	192,124
7. To re-elect Keld van Schreven as a director.	52,081,570	97.0%	1,589,130	3.0%	30.2%	192,124

Extraordinary General Meeting

Resolution	For		Against		Total votes cast as % of Issued Share Capital	Votes Withheld
Number of Votes	% of shares voted	Number of Votes	% of shares voted
1. To adopt the New Articles.	52,305,428	99.7%	165,247	0.3%	29.5%	155,079
2. To authorise the allotment of ordinary shares in connection with the Placing Programme	51,770,426	98.7%	666,587	1.3%	29.5%	188,741
3. To authorise the allotment of ordinary shares in connection with any Performance Fees.	51,798,212	98.8%	636,547	1.2%	29.5%	190,995
4. To authorise the Company to make market acquisitions of ordinary shares.	52,304,435	99.7%	164,600	0.3%	29.5%	156,719

The 'for' votes include those giving discretion to the Chairman.   A 'vote withheld' is not a vote in law and is not counted in the calculation of the votes 'for' or 'against' a resolution.

In accordance with the Company's announcement of 29 October 2025, application has been made to the FCA and the London Stock Exchange for the Company's ordinary shares to be admitted to the equity shares (commercial companies) category of the Official List and to trading on the Main Market of the London Stock Exchange. It is expected that admission will become effective and that dealings in the Company's ordinary shares will commence at 8.00 a.m. on 25 November 2025.

Accordingly, admission of the Company's ordinary shares to trading on the Apex segment of the Aquis Growth Market will be cancelled, with the last day of trading expected to be 24 November 2025.

For further information please contact:

KR1 plc

George McDonaugh, Keld van Schreven

Phone: +44 (0)1624 630 630

Email: [email protected]

AlbR Capital Limited (Aquis Corporate Adviser)

Phone: +44 (0)20 7469 0930

Email: [email protected]

Singer Capital Markets (Sponsor, Financial Adviser and Broker)

Investment Banking: Alex Bond, James Maxwell, James Fischer, Oliver Platts

Equity Sales: William Gumpel, James Waterlow

Phone: +44 (0)20 7496 3000

Email: [email protected]

SEC Newgate (Financial Communications)

Bob Huxford, Ian Silvera, Dafydd Rees

Phone: +44(0)20 3757 6882

Email: [email protected]

About KR1 plc

KR1 plc is a leading digital asset company focused on decentralised technologies and the generation of income from digital assets, primarily through staking activities on proof-of-stake networks. Through the Company's staking activities, KR1 plc helps to secure networks by supporting transaction validation, maintaining network integrity and contributing to decentralisation and, in return, receives staking rewards. www.KR1.io

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXDZMZMDGNGKZM